M3 Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$771K Buy
3,038
+35
+1% +$8.16K 0.4% 46
2026
Q1
$734K Buy
3,003
+134
+5% +$31.2K 0.45% 46
2025
Q4
$594K Buy
2,869
+67
+2% +$13.2K 0.36% 53
2025
Q3
$520K Buy
2,802
+380
+16% +$65.1K 0.32% 61
2025
Q2
$370K Sell
2,422
-169
-7% -$26K 0.26% 74
2025
Q1
$430K Buy
2,591
+444
+21% +$69.5K 0.34% 62
2024
Q4
$310K Sell
2,147
-266
-11% -$41.2K 0.22% 95
2024
Q3
$391K Sell
2,413
-252
-9% -$40.1K 0.29% 80
2024
Q2
$390K Buy
2,665
+40
+2% +$5.95K 0.32% 75
2024
Q1
$415K Sell
2,625
-514
-16% -$81.8K 0.38% 63
2023
Q4
$492K Buy
+3,139
New +$481K 0.58% 38

Other funds holding JNJ

M3 Advisory Group's JNJ Position: Q2 2026 in Review

M3 Advisory Group increased its Johnson & Johnson (JNJ) stake by 1.2% in Q2 2026, buying an estimated $8.16K and bringing the position to 3,038 shares worth $771K. The position accounts for 0.4% of the portfolio, ranked #46.

M3 Advisory Group first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • M3 Advisory Group held 3,038 shares of Johnson & Johnson worth $771K as of Q2 2026.
  • M3 Advisory Group bought 35 Johnson & Johnson shares in Q2 2026, an estimated $8.16K.
  • Johnson & Johnson made up 0.4% of M3 Advisory Group's portfolio in Q2 2026, its #46 holding.
  • M3 Advisory Group first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on M3 Advisory Group's 13F filing for Q2 2026, filed 24 Jul 2026.